Related Experiment Videos
Expression of p53 protein in cutaneous melanoma
1Department of Pathology, Gade Institute, Haukeland Hospital, University of Bergen, Norway.
Abstract:
The purpose of the present study was to examine the expression of p53 protein in malignant melanomas of the nodular sub-type, with special reference to the role of p53 alterations in the development of metastases. Increased expression of p53 protein was found in 29 of 30 cases using PAb1801 monoclonal antibody (MAb) and flow-cytometric detection on archival material. A large proportion of the cells were positive in a majority of the cases. The level of expression was not correlated to DNA ploidy or to subsequent development of local metastases. However, a significant decrease in p53 protein expression was observed in metastatic lesions, as compared with the corresponding primary tumors. Our results indicate that p53 alterations may be an early event in melanoma development, since almost all cases were affected, and that metastatic spread appears to be parallelled by decreased p53 protein expression.
Insights
p53 protein alterations are common in nodular melanoma, potentially an early event. Metastatic spread correlated with decreased p53 protein expression, suggesting its role in melanoma progression.
Area of Science:
- Oncology
- Molecular Biology
- Dermatopathology
Background:
- p53 protein is a tumor suppressor crucial in cell cycle regulation and apoptosis.
- Alterations in p53 are implicated in various cancers, including melanoma.
- Nodular melanoma is an aggressive subtype requiring further understanding of its molecular drivers.
Purpose of the Study:
- To investigate p53 protein expression in nodular melanoma.
- To explore the association between p53 alterations and metastasis development.
- To determine the role of p53 in melanoma progression.
Main Methods:
- Archival nodular melanoma tissue samples were analyzed.
- p53 protein expression was detected using PAb1801 monoclonal antibody.
- Flow cytometry was employed for quantitative assessment of p53 expression.
- Correlation with DNA ploidy and metastatic development was examined.
Main Results:
- Increased p53 protein expression was observed in 29 out of 30 nodular melanoma cases.
- High p53 positivity was noted in a majority of tumor cells.
- No correlation was found between p53 expression levels, DNA ploidy, or local metastasis.
- A significant decrease in p53 protein expression was detected in metastatic lesions compared to primary tumors.
Conclusions:
- p53 alterations appear to be an early event in nodular melanoma development.
- Decreased p53 protein expression is associated with metastatic spread in melanoma.
- These findings highlight the complex role of p53 in melanoma progression and metastasis.